Janssen-Cilag AG - Akeega 50 mg/500 mg, Filmtabletten | | 68977 | | 01 | | Akeega 50 mg/500 mg | | Filmtabletten | | L01XK52 | | | | 18.04.2024 | | |
| Composition | niraparibum 50 mg ut niraparibi tosilas monohydricus 79.7 mg, abirateroni acetas 500 mg corresp. abirateronum 446 mg, hypromellosum, natrii laurilsulfas, lactosum 240.54 mg ut lactosum monohydricum, crospovidonum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, glyceroli monocaprylocapras, talcum, natrii laurilsulfas, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 5.05 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
| 500 mg correspond 446 mg | | 50 mg |
| BAG: Principe actif | Concentr. |
---|
| 500 mg | | 50 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
| | | | | | | | | | | | | | | | | color. | | | color. | | | | Hypromellosum | | | | 240.54 mg | | | | | | | | | | Überzug | | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 56 | 4741.80 | 5172.90 | A | LS | Non |
|
|